Animal Health Market
08 May
Press Release

According to the latest report by IMARC Group, titled “Animal Health Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, The global animal health market was worth more than US$ 44 Billion in 2018. Animal health is one of the most prominent factors that influence the overall productivity of farmers. Regular monitoring of animal health helps in ensuring a safe food supply and preventing the outbreak of various zoonotic diseases. Some of these diseases include feline leukemia, Lyme disease, and tick infestation. The concept of animal health involves the development and production of veterinary drug products that are required to be approved for marketing as well as tested for human toxicology, environmental impacts, and residue levels. These medicines are broadly categorized as pesticides, pharmaceuticals and biologics. On account of these factors, the Animal Health Market value is projected to recah US$ 58 Billion by 2024, grow at a CAGR of around 5% during 2019-2024.

Request for a free sample copy of this report:

Over the years, animal health has become a vital part of the evaluation of the economic growth of several countries. The increase in the global animal health market can be attributed to the rising risk of zoonotic diseases. The World Health Organization (WHO) has been undertaking numerous favorable initiatives to prevent the transmission of these ailments and spread awareness about their presence. Other than this, growth in career opportunities across veterinary medicine and rising social consciousness about optimum animal health have further provided a boost to the market growth.

Buy full report with table of contents:

Key Market Segmentation:

Breakup by Animal Type:

1. Commercial
2. Companion

Breakup by Product:

1. Pharmaceuticals
2. Biologicals
3. Medicinal Feed Additives
4. Diagnostics

Breakup by Region:

1. North America
2. Europe
3. Asia Pacific
4. Middle East and Africa
5. Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players in Animal Health Market Bayer, Elanco, Merck, Merial, Zoetis Inc., Biogenesis Bago, Boehringer Ingelheim, Ceva Sante Animale, Heska, Neogen, Novartis, Thermo Fisher Scientific, Vetoquinol and Virbac.

Key highlights of the report:

1. Market Performance
2. Market Outlook
3. Porter’s Five Forces Analysis
4. Market Drivers and Success Factors
5. SWOT Analysis
6. Value Chain
7. Competitive Structure
8. Profiles of Key Players

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
309 2nd St, Brooklyn, NY 11215, USA
Email: [email protected]
USA: +1-631-791-1145, UK: +44-702-409-7331
Follow us on twitter: @imarcglobal

This post was originally published on Stock Markets News

[email protected]

IMARC Group is a leading market research company that provides market and business research intelligence across the globe. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. We make an effort to fulfill specific and niche requirements of the industry while balancing the quantum of quality with stipulated time and trace major trends at both the domestic and global levels. The information products and services provided by IMARC cover major technological, scientific and economic developments in industrial, pharmaceutical and high technology organizations.